TheraCea Pharma

TheraCea Pharma, founded as a spin-off from the University of Arizona and based in Tucson, is a biotechnology company dedicated to advancing precision medicine for neurological disorders. The company specializes in developing clinical diagnostic tools that enable faster and more accurate detection of cancer and neurological conditions, as well as optimizing therapy matching and assessing therapy efficacy. Utilizing innovative radiochemistry technology, TheraCea focuses on high-efficiency and rapid fluorine-18 radiolabeling of biomolecules for both clinical and research applications.

TheraCea has established significant partnerships with prestigious institutions such as the National Science Foundation and the National Institutes of Health to transition their technology from research to clinical settings. The company has made notable strides in personalized medicine, significantly impacting the early detection and treatment of serious health conditions. Through these collaborations and technological advancements, TheraCea has contributed to enhancing patient outcomes and providing valuable time for both patients and healthcare providers.